A prospective, multicenter, randomized controlled trial comparing VDD-ICD with VVI-ICD in detecting subclinical atrial fibrillation in patients with ICDs: The Dx-AF trial
Open Access
- 23 July 2024
- journal article
- research article
- Published by Elsevier in Heart Rhythm O2
- Vol. 5 (9) , 668-671
Abstract
No abstract availableKeywords
Funding Information
- Biotronik SE & Co KG
This publication has 11 references indexed in Scilit:
- Apixaban for Stroke Prevention in Subclinical Atrial FibrillationNew England Journal of Medicine, 2024
- Anticoagulation with Edoxaban in Patients with Atrial High-Rate EpisodesNew England Journal of Medicine, 2023
- Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipoleEP Europace, 2023
- The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patientsJournal of Interventional Cardiac Electrophysiology, 2017
- VDD vs DDD Pacemakers: A Meta-analysisCanadian Journal of Cardiology, 2014
- Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devicesEP Europace, 2014
- Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association surveyEP Europace, 2013
- Subclinical Atrial Fibrillation and the Risk of StrokeNew England Journal of Medicine, 2012
- Clinical Relevance of Silent Atrial Fibrillation: Prevalence, Prognosis, Quality of Life, and ManagementJournal of Interventional Cardiac Electrophysiology, 2000
- Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trialsJACC, 1998